Stoke Therapeutics STOK
NASDAQ STOK
$26.01 +0.01 (+0.04%)
At close: Oct 1, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Return on Equity [ROE] (2019 - 2026)

Updated

Stoke Therapeutics (STOK) posted Return on Equity [ROE] of -57.10% for Q2 2026, down 71.50 percentage points from 14.40% a year earlier and down 10.73 percentage points from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Return on Equity [ROE] (2019 - 2026) Analysis & Trends

For FY2025, Stoke Therapeutics' Return on Equity [ROE] came in at -7.08%, up 45.09 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of +13.41 percentage points (FY2020 to FY2025).
  • In prior years, Stoke Therapeutics' Return on Equity [ROE] was -52.17% in FY2024 (+14.47 pp), -66.65% in FY2023 (-14.81 pp), -51.84% in FY2022 (-17.68 pp) and -34.16% in FY2021 (-13.67 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q1 2024.
  • On a year-over-year basis, Return on Equity [ROE] increased in six of the last eight quarters, with an average year-over-year change of +21.30 percentage points.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2025, with a gain of 93.93 percentage points; the weakest was Q2 2026, with a drop of 71.50 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -46.37% (Q1 2026), -3.15% (Q4 2025) and 11.63% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Stoke Therapeutics 1.62 Bn 453.12 Mn - -57.10%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -57.10%
Mar 31, 2026 -46.37%
Dec 31, 2025 -3.15%
Sep 30, 2025 11.63%
Jun 30, 2025 14.40%
Mar 31, 2025 16.27%
Dec 31, 2024 -39.97%
Sep 30, 2024 -45.53%
Jun 30, 2024 -56.85%
Mar 31, 2024 -77.66%
Dec 31, 2023 -69.02%
Sep 30, 2023 -61.87%
Jun 30, 2023 -55.58%
Mar 31, 2023 -52.30%
Dec 31, 2022 -53.66%
Sep 30, 2022 -47.48%
Jun 30, 2022 -41.89%
Mar 31, 2022 -41.08%
Dec 31, 2021 -37.80%
Sep 30, 2021 -30.90%
API Access

Stoke Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=STOK&period=max&api_key=YOUR_API_KEY